−560 KRW
−7.22 B KRW
81.14 B KRW
8.19 M
About HANS BIOMED CORPORATION
Sector
Industry
CEO
Geun-Young Kim
Website
Headquarters
Seoul
Founded
1999
ISIN
KR7042520007
FIGI
BBG000D25585
Hans Biomed Corp. engages in the manufacture and sale of graft material and silicon products. Its products include skin and bone graft material, silicon material, and other medical appliances. The company was founded on September 15, 1999, and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 042520 is 9,200 KRW — it has increased by 3.72% in the past 24 hours. Watch HANS BIOMED CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HANS BIOMED CORPORATION stocks are traded under the ticker 042520.
042520 stock has risen by 2.22% compared to the previous week, the month change is a 18.25% rise, over the last year HANS BIOMED CORPORATION has showed a −36.64% decrease.
042520 reached its all-time high on Jan 4, 2018 with the price of 34,750 KRW, and its all-time low was 2,410 KRW and was reached on Mar 21, 2011. View more price dynamics on 042520 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
042520 stock is 5.26% volatile and has beta coefficient of 1.00. Track HANS BIOMED CORPORATION stock price on the chart and check out the list of the most volatile stocks — is HANS BIOMED CORPORATION there?
Today HANS BIOMED CORPORATION has the market capitalization of 115.19 B, it has decreased by −1.44% over the last week.
Yes, you can track HANS BIOMED CORPORATION financials in yearly and quarterly reports right on TradingView.
042520 net income for the last quarter is −6.24 B KRW, while the quarter before that showed 93.69 M KRW of net income which accounts for −6.76 K% change. Track more HANS BIOMED CORPORATION financial stats to get the full picture.
As of Dec 25, 2024, the company has 247.00 employees. See our rating of the largest employees — is HANS BIOMED CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANS BIOMED CORPORATION EBITDA is 4.33 B KRW, and current EBITDA margin is 4.95%. See more stats in HANS BIOMED CORPORATION financial statements.
Like other stocks, 042520 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANS BIOMED CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANS BIOMED CORPORATION technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANS BIOMED CORPORATION stock shows the sell signal. See more of HANS BIOMED CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.